OTC Pharmaceuticals - Lesotho | Statista Market Forecast

In Lesotho, the OTC Pharmaceuticals market is projected to generate a revenue of US$10.79m in 2024.
The market is expected to experience an annual growth rate of 3.99% (CAGR 2024-2029).
Among the different segments, the largest market share belongs to Other OTC Pharmaceuticals, with a market volume of US$5.59m in 2024.
In a global perspective, the United States leads the pack in terms of revenue generation, reaching US$41.24bn in 2024.
When considering the population size, in Lesotho generates a per person revenue of US$4.58 in 2024.
Looking ahead, it is anticipated that online sales will contribute 0.73% of the total revenue in the OTC Pharmaceuticals market by 2024.
Lesotho's OTC Pharmaceuticals market is experiencing a surge in demand for traditional herbal remedies among its population.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Lesotho is experiencing significant growth due to several factors.

Customer preferences: Customers in Lesotho are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This can be attributed to the convenience and accessibility of these products, as they do not require a prescription and can be purchased directly from pharmacies or other retail outlets. Additionally, OTC pharmaceuticals are often more affordable compared to prescription medications, making them a preferred choice for individuals with limited financial resources.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Lesotho is the increasing demand for self-medication. As consumers become more health-conscious and proactive in managing their own health, they are seeking OTC pharmaceuticals to treat common ailments and minor health issues. This trend is driven by factors such as the rising prevalence of chronic diseases, the growing awareness of preventive healthcare, and the availability of information through digital platforms. Another trend in the market is the expansion of the product range offered by OTC pharmaceutical manufacturers. In response to the changing needs and preferences of consumers, companies are introducing a wider variety of OTC products, including vitamins, supplements, and herbal remedies. This diversification of product offerings allows manufacturers to cater to specific health concerns and target different consumer segments.

Local special circumstances: Lesotho, being a small landlocked country, faces unique challenges in its healthcare system. Limited access to healthcare facilities and medical professionals in rural areas often necessitates self-medication and reliance on OTC pharmaceuticals. Additionally, Lesotho has a high burden of communicable diseases such as HIV/AIDS, which further drives the demand for OTC pharmaceuticals for symptom management and treatment of related conditions.

Underlying macroeconomic factors: The OTC Pharmaceuticals market in Lesotho is also influenced by macroeconomic factors such as population growth, urbanization, and economic development. As the population continues to grow and more people migrate to urban areas, the demand for OTC pharmaceuticals is expected to increase. Furthermore, economic development and rising disposable incomes contribute to higher healthcare spending, including the purchase of OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in Lesotho is witnessing growth due to customer preferences for convenient and affordable healthcare solutions. The trends of self-medication and product diversification are driving the market forward. Local special circumstances, such as limited access to healthcare facilities and the high burden of communicable diseases, further contribute to the demand for OTC pharmaceuticals. Finally, underlying macroeconomic factors such as population growth, urbanization, and economic development are also shaping the market in Lesotho.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.